Psychedelic Therapy Blog

Educational articles covering psychedelic therapy research, MDMA-assisted therapy, psilocybin treatment developments, and ketamine therapy updates in California.

Psilocybin has moved from the margins of mental health research into serious discussions about the future of psychiatric treatment. Studies have examined psilocybin-assisted approaches for conditions including depression, treatment-resistant depression, anxiety associated with serious illness, and other mental health concerns. That growing research base has also created understandable confusion about what is actually available. Someone […]

Veterans have played an unusually visible role in the modern psychedelic-therapy conversation, particularly through advocacy and research surrounding MDMA-assisted therapy for PTSD. That focus makes sense, but veteran mental health is much broader than post-traumatic stress disorder alone. Depression, anxiety, grief, substance use, chronic pain, sleep problems, relationship difficulties, and what clinicians sometimes describe as […]

Obsessive-compulsive disorder can be persistent, disabling, and difficult to treat. Established approaches such as Exposure and Response Prevention therapy and certain psychiatric medications help many people, but some continue to experience significant symptoms despite appropriate care. That treatment gap has encouraged researchers to explore new approaches, including psilocybin-assisted therapy. Early findings have generated interest, but […]

Most public discussion about psychedelic therapy focuses on the treatment session itself. Researchers and clinicians often place just as much emphasis on what happens before anyone receives a psychedelic substance. Screening is one of the most important parts of responsible psychedelic-assisted treatment. It helps clinicians understand a person’s medical history, psychiatric history, medications, treatment goals, […]

Ketamine has become increasingly visible in mental health care because of its role in treating certain forms of severe or treatment-resistant depression. As its use has expanded, patients have understandably begun asking whether ketamine may also help anxiety. Researchers have explored ketamine across several anxiety-related conditions, and some findings are encouraging. The evidence is not […]

MDMA has received most of the attention surrounding psychedelic-assisted therapy for post-traumatic stress disorder, but it is not the only psychedelic researchers are interested in. Psilocybin is being investigated across a growing range of psychiatric conditions, raising an obvious question: could it eventually have a role in treating PTSD? At this point, the science is […]

Grief is a normal response to loss, and most people who are grieving do not have a psychiatric disorder that requires treatment. At the same time, grief can become prolonged, disabling, or intertwined with depression, trauma, anxiety, guilt, or difficulty reengaging with everyday life. As psychedelic research has expanded, scientists have started asking whether treatments […]